Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
C-reactive protein (CRP), an active regulator of host innate immunity, is a biomarker of severe COVID-19 disease, including lung and atherosclerotic disease progression
Still, the real test will come in clinical settings
3007-A CLINICAL FEATURES OF ACUTE KIDNEY INJURY-NON HEPATORENAL SYNDROME VERSUS TYPE 1 HEPATORENAL SYNDROME IN PATIENTS WITH CIRRHOSIS AND ASCITES FROM A SINGLE QUATERNARY REFERRAL ACADEMIC CENTRE Neha Tiwari 1 , Chinmay Bera 2 , Cynthia Tsien 3 , Audrey Kapelera 1 , Nazia Selzner 3 and Florence Wong 1 , (1)Division of Gastroenterology and Hepatology, Toronto General Hospital, Toronto, ON, Canada, (2)University Health Network, (3)Ajmera Transplant Center, University of Toronto, Toronto, ON, Canada Background: The re-classification of renal dysfunction in cirrhosis to acute kidney injury (AKI), replacing type 1 hepatorenal (HRS1), is meant to lead to earlier diagnosis and treatment
10.1002/14651858.CD009825.pub2 67
The outcome of corresponding or similar mutations in humans is described, as well as the potential mechanisms underlying increased longevity and the therapeutic benefits and risks of medical disruption of the GH/IGF-1 axis in humans
US$ 24.34
US$ 23.20
US$ 23.13
US$ 22.70
US$ 29.05
US$ 28.47
US$ 28.12
US$ 22.25
